糖皮质激素辅助治疗儿童肺炎支原体大叶性肺炎的疗效

doi:10.7499/j.issn.1008-8830.2014.04.019

Abstract
Figure/Table
References(16)
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (1533 KB) HTML()
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract Objective To study the clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae. Methods One hundred and eight children with lobar pneumonia caused by Mycoplasma pneumoniae were randomly divided into routine treatment and hormone treatment groups. Both groups were treated with azithromycin and other symptomatic therapies. In addition to the basic treatment, the hormone treatment group was given dexamethasone 0.25-0.3 mg/(kg·d) by intravenous drip until the body temperature was normal. Then given oral prednisone tablets 0.5-1 mg/(kg·d) (gradually reduced) for a total treatment course of 7-10 days. Before and after treatment pulmonary functions were examined, and serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-2 (IL-2) and interleukin-6 (IL-6) were measured. Results The duration of fever, cough relief time and pulmonary shadow absorption time on chest X-ray were significantly shorter in the hormone treatment group than in the routine treatment group (PPPConclusions Adjuvant therapy with glucocorticoids can effectively alleviate clinical symptoms, promote the absorption of pulmonary inflammation, and improve pulmonary function in children with lobar pneumonia caused by Mycoplasma pneumoniae.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Yue-Jin
	SUN Jie
	ZHANG Jian-Hua
	FENG Ling-Ling

Key words： Mycoplasma pneumoniae Lobar pneumonia Pulmonary function Glucocorticoid Child

Received: 05 September 2013

Corresponding Authors: 张建华，男，主任医师，教授。

Cite this article:

WU Yue-Jin,SUN Jie,ZHANG Jian-Hua et al. Clinical efficacy of adjuvant therapy with glucocorticoids in children with lobar pneumonia caused by Mycoplasma pneumoniae[J]. CJCP, 2014, 16(4): 401-405.

URL:

http://www.zgddek.com/EN/10.7499/j.issn.1008-8830.2014.04.019 OR http://www.zgddek.com/EN/Y2014/V16/I4/401

[1]	陆权, 陆敏. 肺炎支原体感染的流行病学[J]. 实用儿科临床杂志, 2007, 22(4): 241-243.
[2]	申昆玲, 江载芳. 呼吸系统疾病[M]//胡亚美, 江载芳. 诸福棠实用儿科学(上册). 第7版. 北京: 人民卫生出版社, 2002: 1204-1205.
[3]	安淑华, 李金英, 赵清娟, 等. 常规肺功能检测在儿童支气管哮喘诊疗中的作用[J]. 实用儿科临床杂志, 2011, 26(4): 257-259.
[4]	邢娜, 宋丽君. 儿童大叶性肺炎570例临床分析[J]. 中国妇幼保健, 2010, 25 (2): 195-197.
[5]	岳保珠, 吴春莲, 刘丽平. 儿童肺炎支原体感染性大叶性肺炎10年发病研究[J]. 医学综述, 2010, 16(13): 2071-2073.
[6]	Touati A, Pereyre S, Bouziri A, et al．Prevalence of Mycoplasma pneumoniae-associated respiratory tract infections in hospitalized children: results of a 4-year prospective study in Tunis［J］． Diagn Microbiol Infect Dis, 2010, 68(2): 103-109.
[7]	刘洋, 李敏, 徐佩茹. 肺炎支原体感染发病机制研究进展[J]. 临床儿科杂志, 2011, 29(2): 196-198.
[8]	乔红梅, 庞焕香, 张云峰, 等. 肺炎支原体肺炎患儿IL-6、IL-10、TNF-α的变化[J]. 临床儿科杂志, 2012, 30(1): 59-61.
[9]	中华医学会儿科学呼吸学组, 《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志, 2007, 45(2):83-90.
[10]	陶枫, 王静, 张秋枫. 小剂量激素辅治大叶受累的肺炎支原体肺炎的临床观察[J]. 天津医科大学学报, 2008, 14(2): 187-189.
[11]	张和, 张海邻, 金龙腾, 等. 儿童肺炎支原体肺炎的常规肺功能变化及临床意义[J]. 温州医学院学报, 2011, 41(2): 122-124.
[12]	吴良霞, 吴珉, 顾丹萍. 节段性肺炎支原体的患儿肺功能检测的临床意义[J].中国当代儿科杂志, 2011, 13(3): 185-187.
[13]	郝春莉, 吴良霞, 张建华, 等. 节段性或大叶性肺炎支原体肺炎患儿的肺功能变化[J].临床儿科杂志, 2012, 30(80): 721-723.
[14]	周明娟, 黄绮丹, 林琳. 慢性咳嗽患者小呼吸道病变及呼吸道高反应性对哮喘的预测价值[J]. 中国实用内科杂志, 2007, 27(17): 1370-1372.
[15]	李增清, 陈永新, 钟纪茵, 等. 肺炎支原体感染与支气管哮喘发作关系探讨[J]. 中华医院感染学杂志, 2013, 23(8): 1975-1977.
[16]	Kjaer BB, Jensen JS, Nielsen KG, et al. Lung function and bronchial responsiveness after mycoplasma pneumoniae infection in early childhood[J]. Pediatric Pulmonol, 2008, 43(6): 567-575.